CRISPR Therapeutics AG CRSP
40.89 USD +0.74 (+1.84%)
As ofNov 18, 2026, 2:14 PM EST
40.15 Day range 42.66
39.80 52-week range 63.45
- YTD
- -22.03%
- 1 year
- -23.53%
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate -1.18.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | -1.17 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | -1.04 | -1.15 | -0.11 | -10.58% |
| Aug 3, 2026 | Jun 30, 2026 | -1.19 | -0.94 | +0.25 | +21.01% |
| May 4, 2026 | Mar 31, 2026 | -1.19 | -1.28 | -0.09 | -7.60% |
| Feb 12, 2026 | Dec 31, 2025 | -1.15 | -1.37 | -0.22 | -19.13% |
| Nov 10, 2025 | Sep 30, 2025 | -1.26 | -1.17 | +0.09 | +7.14% |
